Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new footer revision tag 'Revision: v3.3.3' appears, and the 'HHS Vulnerability Disclosure' link and the prior 'Revision: v3.3.2' tag were removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no substantive changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision label has changed from v3.2.0 to v3.3.1, with no visible changes to the study details or related information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe government funding/operating status notice was removed from the page, while the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03071094. The content remains focused on the study design, eligibility criteria, and status.SummaryDifference0.5%

- Check90 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference4%

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.